TD Global Healthcare Leaders ETF (TDOC.TO)
16.98
+0.12 (+0.71%)
CAD |
TSX |
Nov 26, 16:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| -- | -0.19% | 15.31M | 5721.07 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 0.00% | 0.55% | -- | Upgrade |
Basic Info
| Investment Strategy | |
| TD Global Healthcare Leaders Index ETF seeks to track, to the extent reasonably possible and before the deduction of fees and expenses, the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, this TD ETF seeks to track the Solactive Global Healthcare Leaders Index (CA NTR) (or any successor thereto), which tracks the performance of securities of global large and mid-capitalization issuers that are related to healthcare. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | TD Asset Management Inc |
| Prospectus Benchmark Index | |
| Solactive Glb Healthcare Leaders NR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 0.57 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
--
-158.95M
Category Low
1.324B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of October 31, 2021
Performance Versus Category
As of November 26, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of November 26, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Novo Nordisk A/S Class B
|
2.47% | -- | -- |
| Thermo Fisher Scientific Inc | 2.35% | 638.74 | 0.91% |
| Intuitive Surgical Inc | 2.20% | 329.23 | -3.00% |
| Moderna Inc | 2.19% | 329.63 | 20.57% |
| Merck & Co Inc | 2.17% | 79.16 | -3.79% |
| UnitedHealth Group Inc | 2.17% | 439.91 | -2.28% |
| Danaher Corp | 2.17% | 323.96 | 2.69% |
| Pfizer Inc | 2.15% | 54.00 | 6.11% |
| CVS Health Corp | 2.13% | 91.52 | -1.22% |
| Eli Lilly and Co | 2.09% | 260.37 | -0.62% |
News
Headline
Wire
Time (ET)
Yahoo
11/17 08:00
Basic Info
| Investment Strategy | |
| TD Global Healthcare Leaders Index ETF seeks to track, to the extent reasonably possible and before the deduction of fees and expenses, the performance of a global equity index which measures the investment return of global issuers related to healthcare. Currently, this TD ETF seeks to track the Solactive Global Healthcare Leaders Index (CA NTR) (or any successor thereto), which tracks the performance of securities of global large and mid-capitalization issuers that are related to healthcare. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | Sector Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | TD Asset Management Inc |
| Prospectus Benchmark Index | |
| Solactive Glb Healthcare Leaders NR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Not Disclosed | 0.57 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (11-26-21) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 26.63 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of October 31, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 4/7/2021 |
| Last Annual Report Date | 6/30/2021 |
| Last Prospectus Date | -- |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
Yahoo
11/17 08:00